Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease

被引:1
作者
Fan, Yongyan [1 ,2 ]
Ma, Jianjun [1 ,2 ,3 ,4 ]
Yang, Dawei [1 ,2 ]
Li, Xiaohuan [1 ,2 ]
Liang, Keke [2 ,3 ]
She, Zonghan [1 ,2 ]
Qi, Xuelin [1 ,2 ]
Shi, Xiaoxue [1 ,2 ,3 ]
Gu, Qi [1 ,2 ,3 ]
Zheng, Jinhua [1 ,2 ,3 ]
Li, Dongsheng [1 ,2 ,3 ]
机构
[1] Zhengzhou Univ, Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China
[2] Henan Prov Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China
[3] Henan Univ, Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, Peoples Hosp, Dept Neurol, Zhengzhou 450003, Peoples R China
关键词
biomarker; hyperechoic substantia nigra; iron deposition; microglial activation; Parkinson's disease; TRANSCRANIAL BRAIN SONOGRAPHY; IRON ACCUMULATION; URIC-ACID; DIFFERENTIAL-DIAGNOSIS; TASK-FORCE; HYPERECHOGENICITY; ECHOGENICITY; SENSITIVITY; SCALE; REPRODUCIBILITY;
D O I
10.1111/ejn.16308
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study aims to analyse hyperechoic substantia nigra (HSN) characteristics and the correlation of HSN with clinical features and blood biomarkers in patients with Parkinson's disease (PD). Transcranial sonography (TCS) evaluations of the substantia nigra (SN) were performed in 40 healthy controls and 71 patients with PD, including patients with SN hyperechogenicity (SN+) and those with normal SN echogenicity (SN-). Evaluation of motor and non-motor symptoms was assessed by a series of rating scales. The uricase method was used to determine serum uric acid (UA) levels, and enzyme-linked immunosorbent assay (ELISA) was used to measure plasma interleukin (IL)-1 beta levels. TCS showed 92.50% specificity and 61.97% sensitivity in differentiating PD patients from controls. The area of SN+ contralateral to the side of initial motor symptoms (SNcontra) was larger than that ipsilateral to the side of initial motor symptoms (SNipsi). The PDSN+ group had lower Argentine Hyposmia Rating Scale (AHRS) scores and UA levels than the PDSN- group. Binary logistic regression analysis revealed that AHRS scores and UA levels could be independent predictors for HSN. The larger SN echogenic area (SNL) sizes positively correlated with plasma IL-1 beta levels in PD patients with SN+. The present study provides further evidence of the potential of SN echogenicity as an imaging biomarker for PD diagnosis. PD patients with HSN have more severe non-motor symptoms of hyposmia. HSN in PD patients is related to the mechanism of abnormal iron metabolism and microglial activation. Transcranial sonography (TCS) has potential as a tool for Parkinson's disease (PD) diagnosis. Hyperechoic substantia nigra (HSN) is a stable marker during the course of PD and does not reflect disease progression. PD patients with HSN have severer non-motor symptoms of hyposmia. HSN in PD patients is related to the mechanism of abnormal iron metabolism and microglial activation. image
引用
收藏
页码:2702 / 2714
页数:13
相关论文
共 50 条
  • [1] Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease
    Zhou, Hai-Yan
    Huang, Pei
    Sun, Qian
    Du, Juan-Juan
    Cui, Shi-Shuang
    Tan, Yu-Yan
    Hu, Yun-Yun
    Zhan, Wei-Wei
    Wang, Ying
    Xiao, Qin
    Liu, Jun
    Chen, Sheng-Di
    JOURNAL OF PARKINSONS DISEASE, 2018, 8 (02) : 333 - 340
  • [2] Substantia nigra hyperechogenicity in Polish patients with Parkinson's disease
    Ambrosius, W.
    Michalak, S.
    Owecki, M.
    Lukasik, M.
    Florczak-Wyspianska, J.
    Kozubski, W.
    FOLIA MORPHOLOGICA, 2014, 73 (03) : 267 - 271
  • [3] Substantia nigra echogenicity correlated with clinical features of Parkinson's disease
    Zhou, Hai-Yan
    Sun, Qian
    Tan, Yu-Yan
    Hu, Yun-Yun
    Zhan, Wei-Wei
    Li, Dun-Hui
    Wang, Ying
    Xiao, Qin
    Liu, Jun
    Chen, Sheng-Di
    PARKINSONISM & RELATED DISORDERS, 2016, 24 : 28 - 33
  • [4] Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson's Disease
    Prasuhn, Jannik
    Strautz, Robert
    Lemmer, Felicitas
    Dreischmeier, Shalida
    Kasten, Meike
    Hanssen, Henrike
    Heldmann, Marcus
    Brueggemann, Norbert
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (04) : 1191 - 1200
  • [5] Transcranial sonography of the substantia nigra in patients with Parkinson's disease
    Hideto Miwa
    Masae Okawa
    Yoshinori Kajimoto
    Tomoyoshi Kondo
    Journal of Neurology, 2007, 254 : IV15 - IV20
  • [6] Transcranial sonography of the substantia nigra in patients with Parkinson's disease
    Miwa, Hideto
    Okawa, Masae
    Kajimoto, Yoshinori
    Kondo, Tomoyoshi
    JOURNAL OF NEUROLOGY, 2007, 254 (Suppl 4) : 15 - 20
  • [7] Clinical Features in Parkinson's Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study
    Zhu, Sha
    Wang, Yaxi
    Jiang, Yinyin
    Gu, Ruxin
    Zhong, Min
    Jiang, Xu
    Shen, Bo
    Zhu, Jun
    Yan, Jun
    Pan, Yang
    Zhang, Li
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 1593 - 1601
  • [8] Hyperechogenicity of the substantia nigra in Parkinson's disease
    Ressner, Pavel
    Skoloudik, David
    Hlustik, Petr
    Kanovsky, Petr
    JOURNAL OF NEUROIMAGING, 2007, 17 (02) : 164 - 167
  • [9] ACCURACY OF TRANSCRANIAL SONOGRAPHY OF THE SUBSTANTIA NIGRA FOR DETECTION OF PARKINSON'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Tao, Anyu
    Chen, Guangzhi
    Deng, Youbin
    Xu, Renfan
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2019, 45 (03) : 628 - 641
  • [10] Substantia nigra hyperechogenicity in Parkinson's disease
    Bor-Seng-Shu, Edson
    Fonoff, Erich Talamoni
    Barbosa, Egberto Reis
    Teixeira, Manoel Jacobsen
    ACTA NEUROCHIRURGICA, 2010, 152 (12) : 2085 - 2087